2016
Sacks NC , Cabral HJ, Pizer SD, Burgess JF. 2016. Myopic and forward looking behavior in branded oral anti-diabetic consumption: An example from Medicare Part D. Health Econ , May.
View Abstract
Topics: Epidemiology
Sacks NC , Sharma A, Cyr PL , Liu Y , Miller DJ, Chiarella MT, Louie AC. 2016. Outcomes for older patients with acute myeloid leukemia (AML): Multiple hospitalizations and high mortality rates. Value in Health 19(7):A611; doi: 10.1016/j.jval.2016.09.1523 .
View Abstract
Topics: Cancer , Health Economics and Outcomes Research (HEOR)
Proctor DM, Suh M , Mittal L, Hirsch S, Salgado RV, Bartlett C, Van Landingham C, Rohr A, Crump K. 2015. Inhalation cancer risk assessment of hexavalent chromium based on updated mortality for Painesville chromate production workers. J Expo Sci Environ Epidemiol 26(2):224-231. doi: 10.1038/jes.2015.77 . PMID: 26669850.
View Abstract
Topics: Cancer , chromium , risk assessment
Alexander DD, Bylsma LC , Vargas AJ, Cohen SS, Doucette A, Mohamed M, Irvin SR, Miller PE, et al. 2016. Dairy consumption and CVD: A systematic review and meta-analysis. Br J Nutr 115(4):737-750; doi: 10.1017/S0007114515005000 . PMID: 26786887.
View Abstract
Topics: Epidemiology , Food science , meta-analysis , Systematic Review
2015
Katz AJ, Chia VM, Schoonen WM, Kelsh MA . 2015. Acute lymphoblastic leukemia: An assessment of international incidence, survival, and disease burden. Cancer Causes Control 26(11):1627–1642; doi: 10.1007/s10552-015-0657-6 . PMID: 26376890.
View Abstract
Topics: Cancer , Epidemiology
Young RR, Thompson CM, Dinesdurage HR, Elbekai RH, Suh M , Rohr AC, Proctor DM. 2015. A robust method for assessing chemically induced mutagenic effects in the oral cavity of transgenic Big Blue® rats. Environ Mol Mutagen 56(7):629-636; doi: 10.1002/em.21951 . PMID: 25969955.
View Abstract
Topics: mode of action
Thompson CM, Young RR, Suh M , Dinesdurage HR, Elbekai RH, Harris MA, Rohr AC, Proctor DM. 2015. Assessment of the mutagenic potential of Cr(VI) in the oral mucosa of Big Blue® transgenic F344 rats. Environ Mol Mutagen 56(7):621-628; doi: 10.1002/em.21952 . PMID: 26010270.
View Abstract
Topics: chromium
Jensen I , Halbert R, Giuseppe R, Naoshy S, Iqbal SU, Zhimin X, McSweeney P. 2015. A hospital budget impact model to evaluate plerixafor in stem cell mobilization: Impact of primary research and direct stakeholder engagement. Eur J Hosp Pharm 22(3):142–149; doi: 10.1136/ejhpharm-2014-000543 .
View Abstract